tiprankstipranks
Trending News
More News >
Provexis PLC (GB:PXS)
LSE:PXS

Provexis (PXS) Price & Analysis

Compare
2 Followers

PXS Stock Chart & Stats

0.71p
0.02p(3.46%)
At close: 4:00 PM EST
0.71p
0.02p(3.46%)

Provexis News

PXS FAQ

What was Provexis PLC’s price range in the past 12 months?
Provexis PLC lowest share price was 0.40p and its highest was 1.05p in the past 12 months.
    What is Provexis PLC’s market cap?
    Provexis PLC’s market cap is £22.87M.
      When is Provexis PLC’s upcoming earnings report date?
      Provexis PLC’s upcoming earnings report date is Sep 25, 2026 which is in 256 days.
        How were Provexis PLC’s earnings last quarter?
        Currently, no data Available
        Is Provexis PLC overvalued?
        According to Wall Street analysts Provexis PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Provexis PLC pay dividends?
          Provexis PLC does not currently pay dividends.
          What is Provexis PLC’s EPS estimate?
          Provexis PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Provexis PLC have?
          Provexis PLC has 2,345,891,400 shares outstanding.
            What happened to Provexis PLC’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Provexis PLC?
            Currently, no hedge funds are holding shares in GB:PXS
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Provexis PLC

              Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

              Provexis (PXS) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Eco Animal Health
              Chill Brands Group PLC
              Mountfield
              N4 Pharma
              Shield Therapeutics
              Popular Stocks